REGENERON PHARMACEUTICALS INC 4

Accession 0001237899-13-000059

$REGNCIK 0000872589operating

View on SEC.gov Company Profile

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 1:09 PM ET

Size

28.2 KB

Accession

0001237899-13-000059

Insider Transaction Report

Form 4

Period: 2013-11-26

REGENERON PHARMACEUTICALS INCREGN

SHOOTER ERIC M

Director

Transactions

Gift
Common Stock
2013-11-26−7,275→ 910 total(indirect: By Trust)
Gift
Common Stock
2013-11-26−910→ 0 total(indirect: By Trust)
Gift
Class A Stock
2013-08-08−4,857→ 2,643 total(indirect: GRAT self)
Exercise: $0.00→ Common Stock (4,857 underlying)
Gift
Class A Stock
2013-08-08−4,857→ 2,643 total(indirect: By Spouse)
Exercise: $0.00→ Common Stock (4,857 underlying)
Gift
Class A Stock
2013-08-08+9,714→ 15,270 total(indirect: By Trust)
→ Common Stock (9,714 underlying)
Conversion
Common Stock
2013-11-26+8,185→ 8,185 total(indirect: By Trust)
Gift
Class A Stock
2013-06-06−2,778→ 0 total(indirect: By Spouse)
→ Common Stock (2,778 underlying)
Gift
Class A Stock
2013-06-06+5,556→ 5,556 total(indirect: By Trust)
→ Common Stock (5,556 underlying)
Conversion
Class A Stock
2013-11-26−8,185→ 7,085 total(indirect: By Trust)
→ Common Stock (8,185 underlying)
Gift
Class A Stock
2013-06-06+14,444→ 14,444 total(indirect: By Trust)
→ Common Stock (14,444 underlying)
Gift
Class A Stock
2013-06-06−2,778→ 0 total
→ Common Stock (2,778 underlying)

Holdings

Common Stock
(indirect: GRAT self)
2,500
Common Stock
(indirect: By Spouse)
2,500

Footnotes (10)

[F1]The reporting person and his spouse are co-trustees and beneficiaries of the Shooter Family Trust.
[F10]A trust for the benefit of the reporting person's adult daughter, of which the reporting person and his spouse serve as co-trustees.
[F2]Gift of Common Stock to a charitable foundation.
[F3]Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
[F4]Following termination of a GRAT of the reporting person, 2,778 shares of Class A Stock were transferred to the Shooter Family Trust and 7,222 shares of Class A Stock were transferred to a trust for the benefit of the reporting person's daughter, as indicated in this report.
[F5]The reporting person and his spouse each contributed 2,778 shares of Class A Stock to the Shooter Family Trust.
[F6]Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
[F7]Shares of Class A Stock are convertible at any time on a share-for-share basis into Common Stock.
[F8]The reporting person and his spouse each contributed 4,857 shares of Class A Stock received as distribution from their respective GRATs to the Shooter Family Trust.
[F9]Following termination of a GRAT of the reporting person's spouse, 2,778 shares of Class A Stock were transferred to the Shooter Family Trust and 7,222 shares of Class A Stock were transferred to a trust for the benefit of the reporting person's daughter, as indicated in this report.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS INC

CIK 0000872589

→

Entity typeoperating

IncorporatedNY

Related Parties

filerCIK 0000872589

Filing Metadata

Form type: 4
Filed: Nov 28, 7:00 PM ET
Accepted: Nov 29, 1:09 PM ET
Size: 28.2 KB

View on SEC.gov